Amberstone Biosciences
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
23181 Verdugo Dr Ste 106, Laguna Hills, ...Phone Number
(949) 269-7918Website
www.amberstonebio.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
2
About Amberstone Biosciences
Incorporated in 2018, Amberstone Biosciences is an emerging biotherapeutics company developing a novel class of targeted and conditionally active immunotherapeutics to treat solid tumor cancers and other diseases. Amberstone Biosciences' pipeline is driven by an innovative high-throughput single-cell functional discovery platform and strong expertise in an interdisciplinary field of biology, engineering, and therapeutic development.Explore more
Amberstone Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Amberstone Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Amberstone Biosciences is spiking on competitors!
Funding: Get notified immidiatlly once Amberstone Biosciences has new funding data
Congratulate Masked Content for being promoted to Masked Content at Amberstone Biosciences
Check if Amberstone Biosciences has recently received funding, and reach out quickly before it becomes old news!
Amberstone Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Amberstone Biosciences launches new products
Click to see if Amberstone Biosciences had a recent Job posting/layoffs
Earning: See what the market has to say on Amberstone Biosciences recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Amberstone Biosciences
Compare insights from companies similar to Amberstone Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Amberstone Biosciences
<$5M
11-50
Private
$22.5M
2018
YS
Yonglei ShangSenior Vice President and Chief Technology Officer
Company Profile Activity
Activity Insights
Amberstone Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Amberstone Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Amberstone Biosciences.
Amberstone Biosciences financials insights
Gather financial insights about Amberstone Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Angel/Seed
$10.4M
2021
Debt
$133K
2022
Series A
$12M
Amberstone Biosciences Tech Stack
A closer look at the technologies used by Amberstone Biosciences
See more technologies
Amberstone Biosciences News & Media
Amberstone Biosciences Announces Formation of Scientific Advisory Board
LAGUNA HILLS, Calif., June 27, 2022 /PRNewswire/ -- Amberstone Biosciences (www.amberstonebio.com), an emerging biotech company with expertise in developing a new generation of cancer therapeutics, is announcing the formation of a scientific advisory board comprised of industry leaders in...Amberstone Biosciences Emerges with $12 Million for Solid Tumor Therapies | BioSpace
With $12 million in hand from a Series A investment round, Amberstone Biosciences aims at cancer with its highly-differentiated tumor microenvironment-activated therapeutic programs.Amberstone Biosciences Secures $12 Million Series A Financing to Advance Immuno-Oncology Pipeline of Tumor Microenvironment Activated Therapeutics
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Amberstone Biosciences (www.amberstonebio.com), an emerging biotherapeutics company with unique expertise in conditionally active immunotherapeutics, today announced the completion of a $12 million Series A financing round. The funding was led by Viva BioInnovator, Co-win Ventures and Sinovation Ventures, with additional support from ChangRong Capital, Lifespan Investments and existing shareholders. Amberstone will use the proceeds from the financing to ad
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Amberstone Biosciences
Sign Up For FreeTo access detailed company insights
Incorporated in 2018, Amberstone Biosciences is an emerging biotherapeutics company developing a novel class of targeted and conditionally active immunotherapeutics to treat solid tumor cancers and other diseases. Amberstone Biosciences' pipeline is driven by an innovative high-throughput single-cell functional discovery platform and strong experti... Read More
